Trial · NCT03245398
Outcomes12
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Cure Rate (CR) of Mebendazole Against Hookworm | baseline (before treatment) and 18 to 22 days post-treatment | percentage of participants cured | NUMBER | |
| SECONDARY | Geometric Mean Egg Reduction Rate (ERR) of the Two Regimens of Mebendazole Against Hookworm | baseline (before treatment) and 18 to 22 days post-treatment | percentage change | GEOMETRIC_MEAN | |
| SECONDARY | CR of Both Mebendazole Regimens Against Trichuris Trichiura | baseline (before treatment) and 18 to 22 days post-treatment | percentage of participants cured | NUMBER | |
| SECONDARY | Geometric ERR of Both Mebendazole Regimens Against Trichuris Trichiura | baseline (before treatment) and 18 to 22 days post-treatment | percentage of change | MEAN | |
| SECONDARY | Cure Rate (CR) of Both Mebendazole Regimens Against Ascaris Lumbricoides | baseline (before treatment) and 18 to 22 days post-treatment | percentage of participants cured | NUMBER | |
| SECONDARY | Geometric ERR of Both Mebendazole Regimens Against Ascaris Lumbricoides. | baseline (before treatment) and 18 to 22 days post-treatment | percentage change | MEAN | |
| SECONDARY | Arithmetic ERR of the Two Regimens of Mebendazole Against Hookworm | baseline (before treatment) and 18 to 22 days post-treatment | percentage change | MEAN | |
| SECONDARY | Arithmetic ERR of Both Mebendazole Regimens Against Trichuris Trichiura | baseline (before treatment) and 18 to 22 days post-treatment | percentage change | MEAN | |
| SECONDARY | Arithmetic ERR of Both Mebendazole Regimens Against Ascaris Lumbricoides | baseline (before treatment) and 18 to 22 days post-treatment | percentage change | MEAN | |
| OTHER_PRE_SPECIFIED | Comparison of the Sensitivity of Kato Katz to Quantitative Polymerase Chain Reaction (PCR) Assays | 1 year | |||
| OTHER_PRE_SPECIFIED | Prevalence of Genetic Resistance Markers Among Participants | 2 years | |||
| OTHER_PRE_SPECIFIED | Distribution of Hookworm Species Among Participants | 1 year |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03245398/outcomes